These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29175018)

  • 1. Understanding serine proteases implications on Leishmania spp lifecycle.
    Alves CR; Souza RS; Charret KDS; Côrtes LMC; Sá-Silva MP; Barral-Veloso L; Oliveira LFG; da Silva FS
    Exp Parasitol; 2018 Jan; 184():67-81. PubMed ID: 29175018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a Leishmania donovani serine protease inhibitor: Possible role in regulation of host serine proteases.
    Alam MN; Das P; De T; Chakraborti T
    Life Sci; 2016 Jan; 144():218-25. PubMed ID: 26656469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of different serine protease inhibitors in validating the 115 kDa Leishmania donovani secretory serine protease as chemotherapeutic target.
    Chakraborti T; Das P; Choudhury R; De T
    Indian J Biochem Biophys; 2015 Feb; 52(1):14-22. PubMed ID: 26040107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine proteases of Leishmania amazonensis as immunomodulatory and disease-aggravating components of the crude LaAg vaccine.
    de Matos Guedes HL; Pinheiro RO; Chaves SP; De-Simone SG; Rossi-Bergmann B
    Vaccine; 2010 Jul; 28(33):5491-6. PubMed ID: 20472030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmanicidal therapy targeted to parasite proteases.
    Machado PA; Carneiro MPD; Sousa-Batista AJ; Lopes FJP; Lima APCA; Chaves SP; Sodero ACR; de Matos Guedes HL
    Life Sci; 2019 Feb; 219():163-181. PubMed ID: 30641084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine protease activities in Leishmania (Leishmania) chagasi promastigotes.
    da Silva-López RE; dos Santos TR; Morgado-Díaz JA; Tanaka MN; de Simone SG
    Parasitol Res; 2010 Oct; 107(5):1151-62. PubMed ID: 20668879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of serine protease inhibitors on viability and morphology of Leishmania (Leishmania) amazonensis promastigotes.
    Silva-Lopez RE; Morgado-Díaz JA; Chávez MA; Giovanni-De-Simone S
    Parasitol Res; 2007 Nov; 101(6):1627-35. PubMed ID: 17726617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro anti-leishmanial efficacy of potato tuber extract (PTEx): leishmanial serine protease(s) as putative target.
    Paik D; Das P; De T; Chakraborti T
    Exp Parasitol; 2014 Nov; 146():11-9. PubMed ID: 25128800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.
    Souza-Silva F; Bourguignon SC; Pereira BA; Côrtes LM; de Oliveira LF; Henriques-Pons A; Finkelstein LC; Ferreira VF; Carneiro PF; de Pinho RT; Caffarena ER; Alves CR
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1910-8. PubMed ID: 25583728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural proteinaceous inhibitors of serine proteases.
    Debowski D
    Curr Pharm Des; 2013; 19(6):1068-84. PubMed ID: 23016680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A general strategy to inhibit serine protease by targeting its autolysis loop.
    Jiang L; Yuan C; Huang M
    FASEB J; 2021 Feb; 35(2):e21259. PubMed ID: 33417271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical review on marine serine protease and its inhibitors: A new wave of drugs?
    Barzkar N; Khan Z; Tamadoni Jahromi S; Pourmozaffar S; Gozari M; Nahavandi R
    Int J Biol Macromol; 2021 Feb; 170():674-687. PubMed ID: 33387547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailored Ahp-cyclodepsipeptides as Potent Non-covalent Serine Protease Inhibitors.
    Köcher S; Rey J; Bongard J; Tiaden AN; Meltzer M; Richards PJ; Ehrmann M; Kaiser M
    Angew Chem Int Ed Engl; 2017 Jul; 56(29):8555-8558. PubMed ID: 28514117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional attribution of LdISP, an endogenous serine protease inhibitor from Leishmania donovani in promoting infection.
    Alam MN; Chakraborti S; Paik D; Bagchi A; Chakraborti T
    Biochimie; 2018 Apr; 147():105-113. PubMed ID: 29366936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization and characterization of two novel proteases in Leishmania donovani: putative roles in host invasion and parasite development.
    Choudhury R; Das P; De T; Chakraborti T
    Biochimie; 2010 Oct; 92(10):1274-86. PubMed ID: 20595064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ahp cyclodepsipeptides: the impact of the Ahp residue on the "canonical inhibition" of S1 serine proteases.
    Stolze SC; Meltzer M; Ehrmann M; Kaiser M
    Chembiochem; 2013 Jul; 14(11):1301-8. PubMed ID: 23794257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine proteases of parasitic helminths.
    Yang Y; Wen Yj; Cai YN; Vallée I; Boireau P; Liu MY; Cheng SP
    Korean J Parasitol; 2015 Feb; 53(1):1-11. PubMed ID: 25748703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors in potential drug development for Leishmaniasis.
    Das P; Alam MN; Paik D; Karmakar K; De T; Chakraborti T
    Indian J Biochem Biophys; 2013 Oct; 50(5):363-76. PubMed ID: 24772958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A serine protease from a detergent-soluble extract of Leishmania (Leishmania) amazonensis.
    da Silva Lopez RE; De Simone SG
    Z Naturforsch C J Biosci; 2004; 59(7-8):590-8. PubMed ID: 15813385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the serine proteases of the complement system.
    Gál P; Dobó J; Beinrohr L; Pál G; Závodszky P
    Adv Exp Med Biol; 2013; 735():23-40. PubMed ID: 23402017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.